In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Associate Professor Tatjana Potpara
Speaker
Associate Professor Tatjana Potpara
Tatjana Potpara Tatjana Potpara

Belgrade University School of Medicine, Belgrade (Serbia)

Specialities : Atrial Fibrillation , Arrhythmias-General, Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

36 presentations from this speaker

2020 Atrial Fibrillation ESC Guidelines: implications for practice.

Event : Webinar 2020

  • Session : ESC Webinars 2020
  • Speaker : A Rillig (Berlin,DE), TS Potpara (Belgrade,RS), X To be announced (X,FR)

2020 ESC Guidelines on Atrial Fibrillation - Live.

Event : ESC Congress 2020

  • Session : 2020 ESC Guidelines on Atrial Fibrillation - Live
  • Speaker : G Hindricks (Leipzig,DE), IC Van Gelder (Groningen,NL), G Boriani (Castenaso-Bo,IT), GYH Lip (Liverpool,GB), C Blomstrom-Lundqvist (Uppsala,SE), E Arbelo (Barcelona,ES), TS Potpara (Belgrade,RS)

European long-term registries: EURObservational Research Programme on Atrial Fibrillation (EORP-AF) programme.

Event : Webinar 2020

  • Session : EHRA Webinars 2020
  • Speaker : TS Potpara (Belgrade,RS), H Heidbuchel (Antwerp,BE)

European long-term registries: EURObservational Research Programme on Atrial Fibrillation (EORP-AF) programme.

Event : Webinar 2020

  • Session : EHRA Webinars 2020
  • Speaker : TS Potpara (Belgrade,RS), H Heidbuchel (Antwerp,BE)

Hot Line EAST - AFNET 4.

Event : ESC Congress 2020

  • Session : Hot Line EAST - AFNET 4
  • Speaker : B Casadei (Oxford,GB), S Priori (Pavia,IT), P Kirchhof (Hamburg,DE), TS Potpara (Belgrade,RS)

Q&A: overcoming challenges for the benefit of our patients.

Event : ESC Congress 2020

  • Session : Anticoagulation management in non-valvular atrial fibrillation: delivering integrated patient-centred care
  • Speaker : J Steffel (Zurich,CH), TS Potpara (Belgrade,RS), H Heidbuchel (Antwerp,BE)
  • Sponsored by Bristol Myers Squibb and Pfizer

What’s new in the European Society of Cardiology atrial fibrillation management guideline?

Event : ESC Congress 2020

  • Session : Anticoagulation management in non-valvular atrial fibrillation: delivering integrated patient-centred care
  • Speaker : TS Potpara (Belgrade,RS)
  • Sponsored by Bristol Myers Squibb and Pfizer

Why kidneys matter whilst protecting the brain?

Event : ESC Congress 2020

  • Session : A new decade for patients with Atrial Fibrillation: Protect the irreplaceable
  • Speaker : C Ruff (Boston,US), R Kreutz (Berlin,DE), TS Potpara (Belgrade,RS)
  • Sponsored by Bayer AG

An open invitation for science.

Event : EHRA 2019

  • Session : EHRA General Assembly
  • Speaker : TS Potpara (Belgrade,RS)

Anticoagulation and CHA2DS2-VASc score of 1 - PRO

Event : EHRA 2019

  • Session : Knowledge gaps in clinical atrial fibrillation
  • Speaker : TS Potpara (Belgrade,RS)

Arrhythmias during pregnancy.

Event : Webinar 2019

  • Session : EHRA Webinars 2019
  • Speaker : S Ernst (London,GB), TS Potpara (Belgrade,RS)

ELIMINATE-AF Trial - Discussion

Event : EHRA 2019

  • Session : Late-breaking trials 3
  • Speaker : TS Potpara (Belgrade,RS)

Practical tips to optimise stroke prevention with NOACs

Event : ESC Congress 2019

  • Session : Practical tips to optimise stroke prevention with non-vitamin K antagonist oral anticoagulants (NOACs)
  • Speaker : TS Potpara (Belgrade,RS), I Savelieva (London,GB), IC Van Gelder (Groningen,NL)
  • Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

Top Ten Messages from the ESC Guidelines on atrial fibrillation

Event : ESC Congress 2019

  • Session : Atrial fibrillation - The "Big Picture"
  • Speaker : TS Potpara (Belgrade,RS)
  • Cardiology Society of Serbia

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC =2 risk of thromboembolism - CON

Event : EHRA 2018

  • Session : Tough decisions in anticoagulation in atrial fibrillation
  • Speaker : TS Potpara (Belgrade,RS)

Oral anticoagulant therapy for secondary stroke prevention in hypertensive patients

Event : ESC Congress 2018

  • Session : Blood pressure management in acute stroke
  • Speaker : TS Potpara (Belgrade,RS)

Practical tips to improve anticoagulation management in atrial fibrillation.

Event : ESC Congress 2018

  • Session : Practical tips to improve anticoagulation management in atrial fibrillation
  • Speaker : J Steffel (Meilen,CH), TS Potpara (Belgrade,RS), J Oldgren (Uppsala,SE)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Common arrhythmias in hypertension: pathophysiology and consequences

Event : ESC Congress 2017

  • Session : Arrhythmias in hypertension
  • Speaker : TS Potpara (Belgrade,RS)

Evidence for antithrombotic therapy from trials.

Event : EHRA 2017

  • Session : Antithrombotic therapy in valvular atrial fibrillation: joint position document from EHRA and WG thrombosis
  • Speaker : TS Potpara (Belgrade,RS)

High CHADsVASc and NO AF: any indication for anticoagulation?

Event : EHRA 2017

  • Session : Stroke and bleeding in atrial fibrillation: difficult management issues
  • Speaker : TS Potpara (Belgrade,RS)

Management of arrhythmias in hypertension.

Event : EHRA 2017

  • Session : Scientific documents from EHRA
  • Speaker : TS Potpara (Belgrade,RS)

Stroke prevention in atrial fibrillation: should we believe in "Real World Data"?

Event : ESC Congress 2017

  • Session : Stroke prevention in atrial fibrillation: the known knowns and the known unknowns
  • Speaker : TS Potpara (Belgrade,RS)

Use of oral anticoagulants in AF patients undergoing cardioversion.

Event : Webinar 2017

  • Session : EHRA Webinars 2017
  • Speaker : H Heidbuchel (Antwerp,BE), S Hohnloser (Koenigstein,DE), TS Potpara (Belgrade,RS)

What is the correct definition of “non-valvular” atrial fibrillation?

Event : EHRA 2017

  • Session : Anticoagulation for non-valvular atrial fibrillation in 2017
  • Speaker : TS Potpara (Belgrade,RS)
  • Joint session with the Heart Rhythm Society (HRS)

Antithrombotic management for the implantation of CIED and generator changes.

Event : EHRA 2015

  • Session : Antithrombotic management of patients undergoing electrophysiological procedures
  • Speaker : TS Potpara (Belgrade,RS)

Do we still need antiplatelet therapy? The aspirin conspiracy.

Event : EHRA 2015

  • Session : Practical aspects on stroke prevention in atrial fibrillation - what to do in 2015?
  • Speaker : TS Potpara (Belgrade,RS)

Patient and snap-shot surveys.

Event : EHRA 2015

  • Session : EHRA activities in the field of EP Wires, patient and snap-shot surveys. Up-to-date 2015
  • Speaker : TS Potpara (Belgrade,RS)

The use of periprocedural anticoagulation therapy for patients undergoing atrial fibrillation ablation - results of a European snap shot survey.

Event : EHRA 2015

  • Session : Atrial fibrillation registries - of clinical use in daily clinical practice?
  • Speaker : TS Potpara (Belgrade,RS)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are